Clinical Trials Logo

Filter by:
NCT ID: NCT05864365 Enrolling by invitation - Clinical trials for Multiple System Atrophy

Biomarker Study of ATH434 in Participants With MSA

Start date: May 23, 2023
Phase: Phase 2
Study type: Interventional

This study will assess the safety and efficacy of ATH434 in participants with a clinical diagnosis of Multiple System Atrophy

NCT ID: NCT05864235 Enrolling by invitation - Alcohol Consumption Clinical Trials

Texting to Reduce Alcohol Misuse Pilot Trial

TRAM
Start date: May 4, 2023
Phase: N/A
Study type: Interventional

The primary aims of this project are to determine the feasibility and acceptability of recruiting and retaining young adult binge drinkers online and using text messaging to provide weekly Goal Support (GS) or weekly GS + Coaching for Context-specific Peer Support (CCPS) on alcohol consumption. The secondary aims will determine effect sizes for GS and GS+CCPS groups relative to controls on alcohol consumption at 6- and 12-weeks to inform design of an adequately-powered trial.

NCT ID: NCT05863923 Enrolling by invitation - Tobacco Cessation Clinical Trials

Tobacco Cessation Texting Intervention for People Living With HIV Who Smoke in Vietnam

M2Q2-HIV
Start date: April 17, 2023
Phase: N/A
Study type: Interventional

The intersection of smoking and HIV/AIDS poses a serious public health threat in Vietnam. Vietnam is dealing with these two challenges with parallel rather than integrated plans. Using a computer-tailored texting intervention, study investigators seek to promote the use of an underused, available, government-funded resource (the Quitline) and Nicotine Replacement Therapy (NRT) that the quitline provides, thus, promoting cessation among PLWH.

NCT ID: NCT05860777 Enrolling by invitation - Clinical trials for Artificial Intelligence

Harnessing Health IT to Promote Equitable Care for Patients With Limited English Proficiency and Complex Care Needs

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

This is a pragmatic trial that will measure if the use of AI to identify patients with complex care needs and language barriers, as well as active reaching out to clinicians to offer the use of interpreter services will improve the frequency of interpreter use and reduce the time to first interpreter use

NCT ID: NCT05859568 Enrolling by invitation - Hearing Loss Clinical Trials

Baseline Performance and Fitting Parameters for Sonova Products

Start date: April 17, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to assess the effectiveness and optimization of various FDA approved products.

NCT ID: NCT05859204 Enrolling by invitation - Sleep Clinical Trials

Impact of Exercise Groups on Patient Mental Health and Wellbeing in an Acute Psychiatric Inpatient Unit

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

More research is needed to elucidate the impacts of physical activity interventions on short- and long-term activity and neuropsychiatric symptoms (NPS) in psychiatric inpatients and to support its advantageousness when compared to current standards of care. To investigate the impact of regular exercise on activity level, NPS, and sleep in an inpatient psychiatry unit, the investigators propose a placebo-controlled study with measures of activity, mood, anxiety, energy, and sleep as primary outcomes in 50 psychiatric inpatients at Johns Hopkins Hospital. Given the challenges of maintaining blinded assignment to treatment arm, the investigators will compare patients during two time periods (3 months each): the first is treatment as usual (TAU), the second adds exercise intervention (EXI).

NCT ID: NCT05859126 Enrolling by invitation - Clinical trials for Executive Dysfunction

Maternal Choline Supplementation and Offspring Cognition in Adolescence

CholTeens
Start date: June 23, 2023
Phase: N/A
Study type: Interventional

The goal of this 13-year follow up of a randomized control trial is to study the effect of maternal choline supplementation on offspring cognition in adolescence. The main question[s] it aims to answer are: Does a higher dose of maternal choline choline (930 mg/d day supplementation) lead to improved cognition in adolescence including hippocampal-dependent episodic memory and executive functioning when compared to lower dose supplementation (480 mg/d). In this follow-up of a clinical trial participants will complete online cognition testing and emotion testing.

NCT ID: NCT05857488 Enrolling by invitation - Healthy Clinical Trials

Feasibility, Safety and Utility of Endomicroscopy to Study the Intestines of Unsedated Infants at University of Virginia (UVa)

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to demonstrate the feasibility of using the transnasal endomicroscopy (TNE) platform, using intestinal potential difference (IPD) and microbiome brush to evaluate the intestine of unsedated infants.

NCT ID: NCT05854069 Enrolling by invitation - Type 1 Diabetes Clinical Trials

Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes

Start date: April 30, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the efficacy of an adapted FAMS (Family/friend Activation to Motivate Self-care) intervention on CGM use among study participants who are CGM users. We will leverage the infrastructure of an NIDDK-funded RCT evaluating FAMS-T1D among N=280 emerging adults with T1D who have elevated hemoglobin A1c or elevated diabetes distress (NCT05820477). We anticipate at least 50% using CGM to be included in these analyses.

NCT ID: NCT05853939 Enrolling by invitation - Clinical trials for Repetitive Transcranial Magnetic Stimulation

Measuring rTMS-induced Neuroplasticity With EEG Steady-state Visual-evoked Potentials

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The goals of this study are to 1) use EEG steady-state visual evoked potentials as a noninvasive measure of the neuroplasticity induced by repetitive transcranial magnetic stimulation (rTMS), 2) use visual contrast detection paradigms as a behavioral measure of rTMS effects, and 3) to investigate how visual spatial attention augments or suppresses the neuroplastic impact of rTMS. Participants will observe visual stimuli on a screen while allocating their attention to different parts of the visual field and making responses when they observe changes in the visual stimuli. rTMS is performed to visual cortex using MRI-retinotopy neuronavigation. Then the visual task paradigm is performed again.